Intersect ENT XENT announces its next round of earnings this Friday, August 06. Here is Benzinga's everything-that-matters guide for this Friday's Q2 earnings announcement.
What Are Earnings, Net Income, And Earnings Per Share?
Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.
Earnings And Revenue
Analysts are predicting Intersect ENT will report a loss of $-0.43 per share on revenue of $28.02 million. In the same quarter last year, Intersect ENT posted EPS of $0.65 on sales of $9.78 million.
What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?
Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.
If the company were to post earnings in line with the consensus estimate when it reports Friday, EPS would be up 33.85%. Sales would be up 186.5% from the year-ago period. Here is how the company's EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.42 | -0.32 | -0.45 | -0.56 |
| EPS Actual | -0.51 | -0.54 | -0.34 | -0.65 |
| Revenue Estimate | 23.54 M | 27.92 M | 21.37 M | 5.41 M |
| Revenue Actual | 24.33 M | 28.23 M | 22.72 M | 9.78 M |
Want Real-Time Earnings Calendar Updates?
Benzinga consistently updates its earnings calendars to stay up-to-date with the latest company earnings reports. Check out the full earnings calendar list updated in real-time by following this link.
Stock Performance
Shares of Intersect ENT were trading at $24.48 as of August 04. Over the last 52-week period, shares are up 13.86%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Do not be surprised to see the stock move on comments made during its conference call. Intersect ENT is scheduled to hold the call at 08:30:00 ET and can be accessed here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
